• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number D134805
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Cardiac Tamponade (2226)
Event Date 12/03/2021
Event Type  Injury  
Manufacturer Narrative
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that a male patient born (b)(6) underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered cardiac tamponade requiring pericardiocentesis.Patient has a history of paroxysmal afib, also with typical atrial flutter.During the procedure, a pericardial effusion was noticed at the end of the case.The pericardial effusion was confirmed by a pre-effusion check with ultrasound with the ice catheter.The medical intervention provided was a pericardiocentesis and 300cc of fluid were removed and they pulled the drain.The patient was reported to be in stable condition.The physician stated abnormal anatomy and when ablating the ct line.The physician¿s opinion on the cause of this adverse event was the patient¿s unusual/abnormal anatomy, specifically in the right atrium and cavo-tricuspid isthmus, made it difficult to maintain his usual catheter stability when ablating in that area.Patient remained fully recovered with no residual effects.The patient required an overnight stay for observation post pericardiocentesis.He was dismissed the next day with no residual/remaining issues.The bayliss nrg transeptal needle (ref (b)(4)) was used.There was never evidence of a steam pop during the procedure.The pericardial effusion was not appreciated until the final/post intra-cardiac ultrasound imaging was obtained.The physician believed the acute event most likely occurred during ablation of the cti.Irrigated catheter was used in the event and the flow settings were 2ml/min for slow-flow and 15ml/min for high-flow.The correct catheter settings were selected on the generator and the pump was switching from low to high flow during ablation.No error codes were observed during the procedure.Force visualization features used: the force graph, dashboard, and vector were all used throughout the case, as was the visitag module.Visitag settings were 2mm over 3 seconds, with an fot setting of 25% for 3 seconds.Visitag size used was 3mm with no additional filter used with the visitag.Color options used prospectively: visitag color bar range was specific to fti.
 
Manufacturer Narrative
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4) during an internal review on 27-dec-2021, noted a correction to the 3500 initial report as it was missing the physician information.Therefore, updated e.Initial reporter.
 
Manufacturer Narrative
The bwi product analysis lab received the device for evaluation on 12-jan-2022.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
It was reported that a male patient born (b)(6) 1949 underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered cardiac tamponade requiring pericardiocentesis.The device evaluation was completed on 31-jan-2022.The device was returned to biosense webster for evaluation.Bwi conducted a visual inspection and an evaluation of all its features.Visual analysis of the returned device revealed that no damage or anomalies were observed on the smart touch sf (bidirectional).Per the event, several tests were performed.The magnetic, temperature, and force features were tested, and no issues were observed.In addition, the product was deflecting and irrigating correctly.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.All devices are manufactured, inspected, and released to approved specifications as part of bwi's quality process.No malfunction was observed during the product analysis.The instructions for use states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez
MX  
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key13091352
MDR Text Key282813648
Report Number2029046-2021-02257
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835010183
UDI-Public10846835010183
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 02/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/05/2022
Device Model NumberD134805
Device Catalogue NumberD134805
Device Lot Number30653837L
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/12/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/03/2021
Initial Date FDA Received12/28/2021
Supplement Dates Manufacturer Received12/27/2021
01/12/2022
01/31/2022
Supplement Dates FDA Received12/28/2021
01/19/2022
02/17/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/06/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NON BWI- BAYLISS NRG TRANSEPTAL NEEDLE; SMARTABLATE GENERATOR KIT-US; UNKNOWN BRAND ICE CATHETER; UNKNOWN BRAND PUMP; UNK_CARTO 3
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age72 YR
Patient SexMale
-
-